Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 2, 2010, Pages 250-255

  Perrella, A ^a   Sbreglia, C ^a   Atripaldi, L ^a   Esposito, C ^a   D'Antonio, A ^a   Perrella, O ^a  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

Author keywords

Cytokines; Immunology; Viral hepatitis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; INTERFERON PRODUCTION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAPID VIROLOGICAL RESPONSE; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VIRUS LOAD;

ANTIVIRAL AGENTS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON-GAMMA; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; RNA, VIRAL; VIRAL LOAD;

EID: 76749167484     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903428614     Document Type: Article

References (10)

1. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003;9:331-338
2. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5:215-229
3. Ferenci P, Fried MW, Shiffman ML, Smith CI, Marinos G, Gonales FL Jr, et al. Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin. J Hepatol 2005;43:425-433
4. Carreño V, Pardo M, López-Alcorocho JM, Rodríguez- Iñigo E, Bartolomé J, Castillo I. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibodypositive, serum HCV RNA-negative patients with normal alanine aminotransferase levels. J Infect Dis 2006;194:53-60.
5. Barría MI, Vera-Otarola J, León U, Vollrath V, Marsac D, Riquelme A, et al. Influence of extrahepatic viral infection on the natural history of hepatitis C. Ann Hepatol 2008;7: 136-143
6. Halfon P, Bourlière M, Pénaranda G, Khiri H, Ouzan D. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J Clin Microbiol 2006;44: 2507-2511
7. Perrella O, Sbreglia C, Perrella M, Spetrini G, Gorga F, Pezzella M, et al. Interleukin-10 and tumor necrosis factoralpha: model of immunomodulation in multiple sclerosis. Neurol Res 2006;28:193-195
8. Brady MT, MacDonald AJ, Rowan AG, Mills KH. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 2003;33:3448-3457
9. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 2005;41:106-114
10. Ciuffreda D, Comte D, Cavassini M, Giostra E, Bühler L, Perruchoud M, et al. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol 2008;38:2665-2677